Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients
Public ClinicalTrials.gov record NCT02228096. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Single Arm, Multicenter Trial to Determine the Efficacy and Safety of CTL019 in Pediatric Patients With Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia
Study identification
- NCT ID
- NCT02228096
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 75 participants
Conditions and interventions
Conditions
Interventions
- CTL019 T-cells Biological
Biological
Eligibility (public fields only)
- Age range
- 3 Years to 21 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 13, 2014
- Primary completion
- May 28, 2018
- Completion
- May 23, 2019
- Last update posted
- Nov 22, 2020
2014 – 2019
United States locations
- U.S. sites
- 13
- U.S. states
- 12
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Childrens Hospital Los Angeles SC | Los Angeles | California | 90027 | — |
| Stanford University Medical Center | Palo Alto | California | 94304 | — |
| Children's Healthcare of Atlanta SC-2 | Atlanta | Georgia | 30342 | — |
| University of Michigan | Ann Arbor | Michigan | 48109-5941 | — |
| University of Minnesota Medical Center | Minneapolis | Minnesota | 55455 | — |
| Mercy Children's Kansas University | Kansas City | Missouri | 64108 | — |
| Duke University Medical Center | Durham | North Carolina | 27708 | — |
| Cincinnati Children's Hospital | Cincinnati | Ohio | 45230 | — |
| Oregon Health and Science University SC | Portland | Oregon | 97239 | — |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| University of Texas Southwestern Medical Center SC | Dallas | Texas | 75390-9034 | — |
| University of Utah | Salt Lake City | Utah | 84113 | — |
| University of Wisconsin Hospital and Clinics | Madison | Wisconsin | 53705 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02228096, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 22, 2020 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02228096 live on ClinicalTrials.gov.